Safety profile of protein kinase inhibitors in rheumatoid arthritis: a systematic review and meta-analysis
Ann Rheum Dis April 2013; doi:10.1136/annrheumdis-2012-203116
Salgado and colleagues conducted a systematic literature review of the safety profiles of protein kinase inhibitors (PKis) used for the treatment of rheumatoid arthritis (RA). Additionally, the study aims included identification of any class and molecule-related target and off-target adverse events. Data from 11,858 patients across 41 publications (phase 2 and 3 studies and two pooled analyses) were analysed. As well as published trials of PKi in RA, studies on healthy individuals and patients w...